Skip to main content
OpenTrials

Clinical trial condition

Metastatic Solid Tumor

Explore clinical trials studying Metastatic Solid Tumor. Study availability and eligibility vary by location and protocol.

84 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Solid Tumor trial results

Active, not recruiting

A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

NCT05678010

Conditions
Metastatic Cancer, Metastatic Solid Tumor, Metastatic Tumor, +8 more
Locations
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering Westchester (All Protocol Activities) Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
View Trial Details
Active, not recruiting

Study of LP-184 in Patients With Advanced Solid Tumors

NCT05933265

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Norton Healthcare, Inc. Louisville, Kentucky, United States
  • John Hopkins - The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors

NCT03964727

Conditions
Metastatic Solid Tumor, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • USOR - Arizona Oncology - Glendale - Saguaro Cancer Center Glendale, Arizona, United States
  • Arizona Oncology Associates PC-HAL Goodyear, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 65 locations
View Trial Details
Active, not recruiting

A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors

NCT04419532

Conditions
Advanced Cancer, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Cincinnati Cancer Center Cincinnati, Ohio, United States
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
  • National Cancer Center Hospital Chūōku, Japan
View Trial Details
Active, not recruiting

Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation

NCT05919537

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • GenesisCare North Shore Sydney, New South Wales, Australia
  • ICON Cancer Centre South Brisbane Brisbane, Queensland, Australia
  • Southern Oncology Clinical Research Unit Adelaide, South Australia, Australia
  • Cabrini Health Malvern, Victoria, Australia
View Trial Details
Active, not recruiting

TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)

NCT05862324

Conditions
Metastatic Solid Tumor, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • University of Southern California Los Angeles, California, United States
  • University of California San Diego San Diego, California, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

NCT05688280

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +36 more
Locations
  • Miami Cardiac & Vascular Institute Coral Gables, Florida, United States
  • University of Louisville Physicians, PSC Louisville, Kentucky, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Institut Bergonie Bordeaux, France
View all 16 locations
View Trial Details

Related conditions